28 February is Rare Disease Day, and we proudly support this globally-coordinated movement working towards equity in social opportunity, healthcare, and access to diagnosis and therapies for people living with a rare disease.
This year's video features stories of real people all around the world who are living with a rare disease.
At Quanticate, we are delighted to have the opportunity to support Cancer Research UK with their new study DETERMINE (Determining Extended Therapeutic indications for Existing drugs in Rare Molecularly-defined Indications using a National Evaluation platform trial).
A novel umbrella-basket platform design is being used to evaluate the efficacy of licensed therapies for unlicensed indications of rare adult, paediatric and teenage/young adult tumours. The ultimate aim is to provide new treatment options for patients with rare malignancies.
(LONDON UK) - Quanticate, a leading global data-focused Clinical Research Organization (CRO), has named Nick Darbey as the company's Executive Vice President of Business Development.
Drawing on Darbey’s proven track record of growing CROs, Quanticate will leverage his business development leadership to support the growth of the business as he joins the company’s executive team.
Quanticate is exhibiting at this years SCDM 2021 Global Virtual Conference, 26th - 29th September.
Quanticate, a leading global data-focused Clinical Research Organization (CRO), has named Piotr Karasiewicz as the company's new Head of Machine Learning and Digital Transformation to lead process improvements and ensure efficient and high-quality data analysis.
LONDON (UK) - Quanticate, a leading global data-focused clinical research organization (CRO), has launched a new Remote Source Data Verification (RSDV) Platform.
The 21 CFR part 11 compliant cloud-based application allows verification of multiple clinical research sites’ source data to be completed remotely by a specialist team at a centralized location.
We are excited to announce that we have again renewed our MSA with GlaxoSmithKline. Quanticate has been in partnership with GSK for several years and continues this key strategic partnership due to our outstanding quality and ability to deliver on time, every time. We will be supporting GSK on various phases and supplying highly skilled resources supporting various therapeutic areas – using a functional service provision and staff augmentation model. The renewal of this MSA demonstrates GSK’s trust in Quanticate as one of their preferred partners.
About Quanticate
Quanticate is exhibiting at this years PSI Online Conference, 21st - 23rd June 2021 and this years sponsor of the poster session.
Claude Price, Director of Clinical Data Management, will be speaking at the Outsourcing in Clinical Trials UK & Ireland 2021 Virtual Conference on 8th June at 1:50pm.
Deepu Joseph, VP of Clinical Data Management, will be hosting a roundtable discussion at the "Future Trials Roundtable Forum: Decentralized, Direct to Patient & Virtual Clinical Trials" on 13th May 2021 at 11:30 am & 12:30 pm EDT on “Virtual trials from a data perspective”
